United States Healthcare Providers & Services

Ardent Health Inc (ARDT)

Ardent Health Inc experienced four proposed sales totaling approximately 1.57 million dollars by former officer Martin Bonick during late August 2026. These divestments followed a recent earnings report where the company missed expectations by nearly thirty percent. The stock price has risen seven percent over the past ninety days despite this selling activity.
Ticker: ARDT Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Ardent Health Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Bonick Martin Former Officer & Director Executive Director
Transaction date
Proposed sale
Price
187.06
Quantity 47,687
Value US$4,690,361
Bonick Martin Former Officer & Director Executive Director
Transaction date
Proposed sale
Price
291.65
Quantity 71,379
Value US$4,771,508
Bonick Martin Former Officer & Director Executive Director
Transaction date
Proposed sale
Price
27.16
Quantity 60,572
Value US$1,704,996
Bonick Martin Former Officer & Director Executive Director
Transaction date
Proposed sale
Price
10.95
Quantity 35,930
Value US$393,482
3.9
DeMichiei Robert Non-Executive Director
Transaction date
Purchase
Price
8.73
Quantity 11,260 +46.3%
Value US$98,300
3.2
LUMSDAINE ALFRED Chief Financial Officer Officer
Transaction date
Purchase
Price
8.81
Quantity 10,000 +3.1%
Value US$88,100
1.0
Webb Robert Thomas Non-Executive Director
Transaction date
Purchase
Price
16.49
Quantity 10,000 +33.0%
Value US$164,900
1.0
Webb Robert Thomas Non-Executive Director
Transaction date
Purchase
Price
17.47
Quantity 10,000 +49.3%
Value US$174,700
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-27 2026-08-27 PrS Proposed sale
Bonick Martin

Former Officer & Director

Executive Director
47,687
187.06
US$4,690,361 		47,687 187.06 US$4,690,361
2026-08-25 2026-08-25 PrS Proposed sale
Bonick Martin

Former Officer & Director

Executive Director
71,379
291.65
US$4,771,508 		71,379 291.65 US$4,771,508
2026-08-20 2026-08-20 PrS Proposed sale
Bonick Martin

Former Officer & Director

Executive Director
60,572
27.16
US$1,704,996 		60,572 27.16 US$1,704,996
2026-08-18 2026-08-18 PrS Proposed sale
Bonick Martin

Former Officer & Director

Executive Director
35,930
10.95
US$393,482 		35,930 10.95 US$393,482
2026-06-08 2026-06-05 B Purchase
3.9
DeMichiei Robert
Non-Executive Director
11,260 +46.3%
8.73
US$98,300 		11,260 +46.3% 8.73 US$98,300
2026-06-08 2026-06-05 B Purchase
3.2
LUMSDAINE ALFRED

Chief Financial Officer

Officer
10,000 +3.1%
8.81
US$88,100 		10,000 +3.1% 8.81 US$88,100
2024-11-13 2024-11-08 B Purchase
1.0
Webb Robert Thomas
Non-Executive Director
10,000 +33.0%
16.49
US$164,900 		10,000 +33.0% 16.49 US$164,900
2024-11-13 2024-11-08 B Purchase
1.0
Webb Robert Thomas
Non-Executive Director
10,000 +49.3%
17.47
US$174,700 		10,000 +49.3% 17.47 US$174,700
Explore more

More insider trading research around Ardent Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America